$GRCE News

Grace Therapeutics: Assessing The Path Forward For GTx-104

TD Cowen Maintains Buy on Grace Therapeutics, Lowers Price Target to $8

Grace Therapeutics Stock Falls As FDA Declines To Approve Brain Hemorrhage Drug

Grace Therapeutics Shares Resume Trade

Grace Therapeutics Shares Resume Trade

Grace Therapeutics Shares Resume Trade Then Halted On Circuit Breaker To The Downside, Stock Now Down -52.44%

Trading Halt: Halt status updated at 1:35:00 PM ET: Quotation Resumption: News and Resumption Times

Grace Therapeutics, Inc. Receives FDA Complete Response Letter For GTx-104, No New Clinical Data Required; Intends To Resubmit Application Following Resolution Of Cited Items

Trading Halt: Halted at 12:27:43 p.m. ET - Trading Halt: Halt News Pending

Grace Therapeutics Announces Abstract Highlighting STRIVE-ON Phase 3 Trial Results Accepted for Presentation at AAN 2026

Grace Therapeutics shares are trading higher after the company announced an abstract for the results for its STRIVE-ON Phase 3 Safety Trial.

Grace Therapeutics Announces Acceptance Of Abstract Highlighting Results From STRIVE-ON Phase 3 Safety Trial For Presentation At 2026 American Academy of Neurology Meeting, April 18-22

Grace Therapeutics Announces Abstract Highlighting STRIVE-ON Phase 3 Safety Trial Results At American Academy Of Neurology Annual Meeting

We're Not Very Worried About Grace Therapeutics' (NASDAQ:GRCE) Cash Burn Rate

Grace Therapeutics to Present Data on the Unmet Medical Needs and Potential Benefits of GTx-104 in the Treatment of aSAH at Upcoming Medical Conferences

Grace Therapeutics To Highlight Data On the Unmet Medical Needs And Potential Benefits Of GTx-104 in the Treatment of aSAH at Upcoming Medical Conferences

Grace Therapeutics to Participate in the TD Cowen 46th Annual Health Care Conference

Grace Therapeutics Announces Third Quarter 2026 Financial Results, Provides Business Update

Grace Therapeutics Q3 EPS $(0.14) Beats $(0.28) Estimate

Grace Therapeutics to Participate in 16th Annual Craig-Hallum Alpha Select Conference